SRC and cancer: Since Src (a protein tyrosine kinase) modifies the membrane-associated guanylate kinase, WW, and 1-containing PDZ structural domain (MAGI1) in the mIDH1 CCA, mIDH1/2 cancers are dependent on Src kinase signaling and sensitive to Src inhibition [119].